Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ion Channels | 12 | 2016 | 235 | 1.400 |
Why?
|
| NADPH Oxidases | 7 | 2014 | 55 | 0.840 |
Why?
|
| Protons | 8 | 2011 | 104 | 0.780 |
Why?
|
| Neutrophils | 3 | 2014 | 111 | 0.740 |
Why?
|
| Ion Channel Gating | 8 | 2016 | 195 | 0.740 |
Why?
|
| Eosinophils | 3 | 2006 | 47 | 0.520 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 12 | 0.440 |
Why?
|
| Phagocytosis | 1 | 2009 | 44 | 0.330 |
Why?
|
| Phospholipases A | 1 | 2006 | 7 | 0.270 |
Why?
|
| Granulocytes | 1 | 2006 | 16 | 0.270 |
Why?
|
| Protein Kinase C | 1 | 2006 | 48 | 0.270 |
Why?
|
| Respiratory Burst | 3 | 2014 | 34 | 0.250 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2010 | 150 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 3 | 2014 | 113 | 0.190 |
Why?
|
| Mutation | 4 | 2016 | 352 | 0.170 |
Why?
|
| Animals | 8 | 2016 | 3750 | 0.170 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 12 | 0.170 |
Why?
|
| Trastuzumab | 1 | 2020 | 27 | 0.170 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2009 | 40 | 0.170 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 17 | 0.170 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 52 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 64 | 0.160 |
Why?
|
| Enzyme Activation | 4 | 2010 | 119 | 0.160 |
Why?
|
| Mice | 5 | 2010 | 1445 | 0.150 |
Why?
|
| Zinc | 4 | 2010 | 47 | 0.140 |
Why?
|
| Humans | 14 | 2020 | 28181 | 0.130 |
Why?
|
| Phagocytes | 2 | 2008 | 24 | 0.130 |
Why?
|
| Proton Pumps | 2 | 2008 | 16 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 90 | 0.120 |
Why?
|
| Benzopyrans | 2 | 2009 | 9 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 117 | 0.100 |
Why?
|
| Basophils | 2 | 2010 | 9 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 36 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2010 | 316 | 0.100 |
Why?
|
| Aspartic Acid | 1 | 2011 | 14 | 0.100 |
Why?
|
| Maleimides | 2 | 2009 | 8 | 0.090 |
Why?
|
| Carcinogens | 2 | 2009 | 11 | 0.090 |
Why?
|
| Indoles | 2 | 2009 | 38 | 0.090 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2008 | 14 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 119 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
| Threonine | 1 | 2009 | 10 | 0.080 |
Why?
|
| Naphthols | 1 | 2009 | 4 | 0.080 |
Why?
|
| Rhodamines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Leukocytes | 1 | 2009 | 37 | 0.080 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 8 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 57 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 176 | 0.080 |
Why?
|
| Membrane Potentials | 2 | 2010 | 182 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 12 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2010 | 447 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 49 | 0.070 |
Why?
|
| Okadaic Acid | 1 | 2006 | 6 | 0.070 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 8 | 0.070 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2006 | 45 | 0.070 |
Why?
|
| Electrophysiology | 4 | 2010 | 103 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 105 | 0.070 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2005 | 8 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 438 | 0.060 |
Why?
|
| Adult | 2 | 2009 | 8091 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 12 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 22 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 29 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2016 | 74 | 0.050 |
Why?
|
| Histidine | 2 | 2011 | 8 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cell Survival | 1 | 2020 | 120 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2010 | 83 | 0.040 |
Why?
|
| Kinetics | 2 | 2010 | 193 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 114 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 178 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 253 | 0.040 |
Why?
|
| Cell Line | 2 | 2010 | 278 | 0.040 |
Why?
|
| Isotonic Solutions | 2 | 2011 | 10 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 424 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2011 | 10 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 7 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 19 | 0.020 |
Why?
|
| Sucrose | 1 | 2011 | 18 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 22 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 15 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2011 | 71 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 118 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 6 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 19 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 18 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 39 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 23 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 20 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 10 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 129 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 65 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 57 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 10 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 24 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 25 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 118 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 51 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 71 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 147 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 12 | 0.020 |
Why?
|
| Acids | 1 | 2004 | 4 | 0.010 |
Why?
|
| Zinc Compounds | 1 | 2004 | 5 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 6 | 0.010 |
Why?
|
| Chlorides | 1 | 2004 | 26 | 0.010 |
Why?
|
| Potassium | 1 | 2004 | 63 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 85 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 338 | 0.010 |
Why?
|
| Cadmium | 1 | 2003 | 13 | 0.010 |
Why?
|
| Superoxides | 1 | 2003 | 25 | 0.010 |
Why?
|
| Female | 1 | 2020 | 15692 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 538 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 43 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 674 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 328 | 0.010 |
Why?
|
| Male | 1 | 2004 | 15232 | 0.000 |
Why?
|